CAR T cell therapy for T cell leukemia and lymphoma: latest updates from 2022 ASH Annual Meeting

Overview of attention for article published in Journal of Hematology & Oncology, March 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (56th percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

So far, Altmetric has seen 4 tweets from 4 users, with an upper bound of 6,864 followers.

RT @Lymphoma_Papers: CAR T cell therapy for T cell leukemia and lymphoma: latest updates from 2022 ASH Annual Meeting #lymphoma #lymsm http…

RT @Lymphoma_Papers: CAR T cell therapy for T cell leukemia and lymphoma: latest updates from 2022 ASH Annual Meeting #lymphoma #lymsm http…

RT @Lymphoma_Papers: CAR T cell therapy for T cell leukemia and lymphoma: latest updates from 2022 ASH Annual Meeting #lymphoma #lymsm http…

CAR T cell therapy for T cell leukemia and lymphoma: latest updates from 2022 ASH Annual Meeting #lymphoma #lymsm https://t.co/mlspnSMaLE

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity.